Main > ONCOLOGY (**) > Lung>NSCLC>EGFR+>MET>*** > Treatment > Co: UK. A. Osimertinib > (*) BR 1st Line OK: 2018. 04.16.

---

(*) BR 1st Line OK: 2018. 04.16.'s products
This section has no products